Regencell Bioscience’s Investigational Liquid-Formula RGC-COV19TM Shows Effectiveness Through Its Enrolled Patients in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-day Treatment Period in its EARTH Efficacy Trial
36 out of 37 COVID-19 patients treated in the trial, representing approximately 97.3% of the patients, reported they had all[…]
Read more